Source: ST. LOUIS BUSINESS JOURNAL

Euclises: Euclises co-founder named one of world's most important drug discoverers

John Talley, chief scientific officer and co-founder of Euclises Pharmaceuticals, a St. Louis biotech startup developing cancer treatments, has been named by The Medicine Maker as one of the world's most influential people in drug discovery and development. Talley was recognized by the U.K.-based maagine as one of 100 scientists and entrepreneurs to make up its annual Power List. Talley came in at No. 11 on the list as co-inventor of eight marketed drugs that have achieved more than $40 billion...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Bobby W. Sandage's photo - President & CEO of Euclises

President & CEO

Bobby W. Sandage

CEO Approval Rating

79/100

Read more